FOLLOWUS
Influence of Fuzheng Huayu Tablet (扶正化瘀片) on mental state and social function of patients with post-hepatitis B liver cirrhosis
Influence of Fuzheng Huayu Tablet (扶正化瘀片) on mental state and social function of patients with post-hepatitis B liver cirrhosis
- 中国结合医学杂志（英文版） 2012年18卷第6期 页码：466-472
- Affiliations：
Ruikang Hospital affiliated to Guangxi Traditional Chinese Medicine College,Nanning,China
- Author bio：
- Funds：Supported by Project of Guangxi Science and Technology Department (No. 2010 GXNSFA 013217), Key Project of Guangxi Health Department (No. 2010095) and Guangxi Provincial Fund of Natural Science (No. Gui Ke Zi 0832174)
DOI：10.1007/s11655-012-1112-0
中图分类号：纸质出版日期：2012，
网络出版日期：2012-7-22，
Scan for full text
Deng, X., Liang, J., Wu, Fs. et al. Influence of Fuzheng Huayu Tablet (扶正化瘀片) on mental state and social function of patients with post-hepatitis B liver cirrhosis., Chin. J. Integr. Med. 18, 466–472 (2012). https://doi.org/10.1007/s11655-012-1112-0
Xin Deng, Jian Liang, Fa-sheng Wu, et al. Influence of Fuzheng Huayu Tablet (扶正化瘀片) on mental state and social function of patients with post-hepatitis B liver cirrhosis[J]. Chinese Journal of Integrative Medicine, 2012,18(6):466-472.
Deng, X., Liang, J., Wu, Fs. et al. Influence of Fuzheng Huayu Tablet (扶正化瘀片) on mental state and social function of patients with post-hepatitis B liver cirrhosis., Chin. J. Integr. Med. 18, 466–472 (2012). https://doi.org/10.1007/s11655-012-1112-0 DOI：
Xin Deng, Jian Liang, Fa-sheng Wu, et al. Influence of Fuzheng Huayu Tablet (扶正化瘀片) on mental state and social function of patients with post-hepatitis B liver cirrhosis[J]. Chinese Journal of Integrative Medicine, 2012,18(6):466-472. DOI： 10.1007/s11655-012-1112-0.
摘要
To observe the influence of Fuzheng Huayu Tablet (扶正化瘀片
FZHYT) on mental state and social activity of patients with post-hepatitis B liver cirrhosis (LC-HB). Adopting grouped randomized double-blinded control method
180 LC-HB patients in 3 research centers were distributed to 2 groups
the treated group and the control group
90 in each group. Patients in the treated group were administered with FZHYT; while those in the control group treated with conventional therapy combined with placebo
the course for all patients were 6 months. Their mental state and social activity were evaluated before treatment
after 3 months’ treatment and at terminal of the 6-month therapeutic course by estimating with Zung self-rating anxiety scale (SAS)
self-rating depression scale (SDS) and social deficit screening scale (SDSS). Additionally
the basic demographic materials
liver function
cirrhosis index
hepatic and splenic images
blood coagulation function
etc. in the patients were tested and compared as well. As compared with before treatment
the normal rate of SAS and SDS scores increased and the social deficit rate decreased in the treated group significantly after treatment
showing statistical significance (P<0.05 or P<0.01); while in the control group
change was only shown in the social deficit (P<0.01)
inter-group comparisons after treatment showed significant differences in all the three indexes (P<0.05 or P<0.01). Additionally
after treatment
levels of liver function
cirrhosis
blood coagulation function and splenomegaly in the treated group were all improved significantly P<0.05 or P<0.01)
and the improvements were better than those in the control group (P<0.01) in levels of total bilirubin (TBIL)
albumin (ALB)
type IV collagen (IV-C)
prothrombin time (PT)
prothrombin activity (PTA). Most patients of LC-HB have mental disturbance and social activity deficit
which could definitely be improved by intervention with Chinese FZHYT.
Abstract
To observe the influence of Fuzheng Huayu Tablet (扶正化瘀片
FZHYT) on mental state and social activity of patients with post-hepatitis B liver cirrhosis (LC-HB). Adopting grouped randomized double-blinded control method
180 LC-HB patients in 3 research centers were distributed to 2 groups
the treated group and the control group
90 in each group. Patients in the treated group were administered with FZHYT; while those in the control group treated with conventional therapy combined with placebo
the course for all patients were 6 months. Their mental state and social activity were evaluated before treatment
after 3 months’ treatment and at terminal of the 6-month therapeutic course by estimating with Zung self-rating anxiety scale (SAS)
self-rating depression scale (SDS) and social deficit screening scale (SDSS). Additionally
the basic demographic materials
liver function
cirrhosis index
hepatic and splenic images
blood coagulation function
etc. in the patients were tested and compared as well. As compared with before treatment
the normal rate of SAS and SDS scores increased and the social deficit rate decreased in the treated group significantly after treatment
showing statistical significance (P<0.05 or P<0.01); while in the control group
change was only shown in the social deficit (P<0.01)
inter-group comparisons after treatment showed significant differences in all the three indexes (P<0.05 or P<0.01). Additionally
after treatment
levels of liver function
cirrhosis
blood coagulation function and splenomegaly in the treated group were all improved significantly P<0.05 or P<0.01)
and the improvements were better than those in the control group (P<0.01) in levels of total bilirubin (TBIL)
albumin (ALB)
type IV collagen (IV-C)
prothrombin time (PT)
prothrombin activity (PTA). Most patients of LC-HB have mental disturbance and social activity deficit
which could definitely be improved by intervention with Chinese FZHYT.
关键词
post-hepatitis B liver cirrhosisFuzheng Huayu Tabletmental statesocial activity
Keywords
post-hepatitis B liver cirrhosisFuzheng Huayu Tabletmental statesocial activity
references
Lu ZY, Zhong NS. Internal medicine science (7th ed). Beijing: People’s Medical Publishing House; 2008:453–454.
Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Lédinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009;29:242–249.
Li WY, Jiang YF, Jin QL Zhang H, Feng XW, Niu JQ. Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection. J Biomed Biotechnol 2010;14:138–145.
Anna S, Brian J. Chronic hepatitis B. Hepatology 2007;45:507–538.
Jordi B, Morris S, Josep M. Clinical management of hepatocellular carcinoma.conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421–430.
Yang HZ, Wang FL, Wang YZ, Shen WS, Xu GL, Yang YW, et al. The clinical study on chronic hepatitis B treated by the four-step therapeutics of traditional Chinese medicine. J Chin Med Mat (Chin) 2006;29:748–752.
Shi WQ, Ru QJ, Cai GY. Effect of umbilical sticking therapy with Qi Tou Xiao Gu plaster in treating liver cirrhosis patients with portal hypertension. Chin J Integr Tradit West Med (Chin) 2008;28:642–647.
Den X, Liang J, Wu FS, Li YB, Tang YF. Influence of traditional Chinese medicine therapy on quality of life of patients with posthepatitic cirrhosis. Lishizhen Med Mater Med Res (Chin) 2010;21:3314–3316.
Liang J, Den X, Yu L, Wu FS, Li X, An YH. Study on the establishment of the evaluation index system of Chinese medicine treatment of hepatitis cirrhosis. Liaoning J Tradit Chin Med (Chin) 2009;6:2017–2019.
Digestive System Disease Committee of Chinese Association of integrative Medicine. Cirrhosis of combining traditional Chinese and western medicine treatment scheme (draft). Chin J Integr Tradit West Med (Chin) 2004;24:869–871.
European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397–417.
Santini MT, Rainaldi G, Indovina PL. Multicelluar tumour spheroids in radiation biology. Int J Radiat Biol 1999;75:787–789.
Zhang MY. Manual of rating scales for psychiatry. Changsha: Hunan Science and Technology Press; 1993:162–164.
Tan CY, Liu P. Theoretical origin of pathogenesis on accumulation due to deficiency of liver cirrhosis and clinical significance. Acta Univ Tradit Med Sin Pharmacol Shanghai (Chin) 2010;24(4):25–28.
Zhang Q, Liu P, Zhang HW, Wang L, Dou GL, Chen HF, et al. Study on the patterns of TCM syndrome differentiation of 900 patients with posthepatitic cirrhosis. Chin J Integr Tradit West Med (Chin) 2006;26:694–697.
Yuan Z. Clinical applicative characteristics of biopsychosocial medical mode. Chin J Clin Rehabilit (Chin) 2005;9:252–253.
Kim SH, Oh EG, Lee WH. Symptom exper ience, psychological distress, and quality of life in Korean patients with liver cirrhosis: a cross-sectional survey. Int J Nurs Stud 2006;43:1047–1056.
Tang JS, Xu CM, Zhai J, Zhao GF, Li CQ, Liang YR. A study on the relationship of social disability to subjective support and the degree of condition in patients with anxiety. Chin J Clin Rehabilit (Chin) 2003;7:2568–2569.
Zandi M, Adib-Hajbagheri M, Memarian R, Nejhad AK, Alavian SM. Effects of a self-care program on quality of life of cirrhotic patients referring to Tehran Hepatitis Center. Health Qual Life Outcomes 2005;18;3:35.
Luk JM, Wang X, Liu P, Wong KF, Chan KL, Tong Y, et al. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer:from laboratory discovery to clinical evaluation. Liver Int 2007;27:879–890.
Li YM, Yang HZ, Guan WB, Ke QS, Dai M, Xie HP, et al. Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients. World J Gastroenterol 2008;14:6060–6063.
Huang J, Huang H, Jiao Y, Ai G, Huang T, Li L, et al. Effect of anluohuaxian tablet combined with gamma-IFN on schistosomal liver fibrosis. J Huazhong Univ Sci Technol Med Sci (Chin) 2009;29:53–61.
Tong GD, Zhou DQ, He JS, Zhang L, Chen ZF, Xiao CL, et al. Clinical research on navel application of Shehuang Paste combined with Chinese herbal colon dialysis in treatment of refractory cirrhotic ascites complicated with azotemia. World J Gastroenterol 2006;12:7798–7804.
Liang J, Qin LK, Den X, Wu FS, Li X, An YH. Systematic review of therapeutic effects of traditional Chinese medicine on posthepatitic cirrhosis at early stage. Acta Univ Tradit Med Sin Pharmacol Shanghai (Chin) 2009;23:20–23.
Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther 2009;30:469–476.
Jin S, Yan L, Li B, Wen T, Zhao J, Zeng Y, et al. Quality of life and psychologic distress of recipients after adult livingdonor liver transplantation (LDLT)-A study from mainland China. Transplant Proc 2010;42:2611–2616.
0
浏览量
82
Downloads
6
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 邮编：100091
- 联系电话：010-62886827, 62877592 传真：010-62874291
- 技术支持由北京北大方正电子有限公司提供 京ICP备05067934号-1
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
